Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Endometrial Neoplasms 12Polycystic Ovary Syndrome 4Endometrial Hyperplasia 4Infertility 3Neoplasms 2Anovulation 2Vitamin D Deficiency 1Turcot syndrome 1Overweight 1Obesity 1Menorrhagia 1Leiomyoma 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Adenocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Endometrioid 1Breast Neoplasms 1Advanced, Persistent, or Recurrent Endometrial Cancer 1Adenocarcinoma 1

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Obesity × Medroxyprogesterone Acetate × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡